Search company, investor...
Genflow company logo

Genflow

genflow.com

Founded Year

2016

Stage

Growth Equity | Alive

Total Raised

$11M

Last Raised

$11M | 2 yrs ago

About Genflow

Genflow markets itself as a “brand-as-a-service” (BAAS) platform, which helps influencers create and sell their own products — digital or physical, — as well as manage the community.

Headquarters Location

London, England, WC1A 2TH,

United Kingdom

Missing: Genflow's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Genflow's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Genflow

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Genflow is included in 1 Expert Collection, including Influencer & Content Creator Tech.

I

Influencer & Content Creator Tech

327 items

These companies offer tech-enabled solutions to connect influencers with advertisers, facilitate the creation and management of influencer campaigns, as well as provide tools and services to the influencer community.

Latest Genflow News

Proactive news headlines: Immupharma, Franchise Brands, Evgen, Genflow and more

May 25, 2022

Goodbody Health Inc (AQSE:GBDY, CSE:GBDY, OTC:SCNNF) cheered its highest quarterly profit to date, driven by a 276% jump in year-on-year revenues generated through its patient testing operations. The company said it experienced a strong continuation of bookings for Covid PCR tests during the first quarter and as a result, the company’s transition to wellness testing has moved back into the second and third quarters. Synairgen PLC (AIM:SNG, OTC:SYGGF) said it is “working in haste” on new trials as it remains encouraged that its lead drug still has potential for patients with severe viral lung infections. The drug developer reported results for last calendar year showing a loss from operations of £57.9mln compared to £17.7mln, as research and development expenditure increased to £52.9mln from £15.5mln as it carried out Phase 3 trial and manufacturing activities. Evgen Pharma PLC (AIM:EVG) has announced a new collaboration with professor Francesco Marampon at Università Sapienza di Roma (La Sapienza) in which they will together investigate potential radiosensitisation effects of Evgen's lead asset, SFX-01. The aim of radiosensitisation is to make tumour cells more sensitive to radiation therapy and through this, to improve effectiveness, the company noted. Kromek Group PLC (AIM:KMK)  said it has won a repeat order worth US$695,000 from a US federal entity for its D3S-ID wearable nuclear radiation detector. The order is to be delivered in the coming months, the company said, following on from a US$1.6m two-year contract from the same customer last September. The patents applications are filed in the US under the Patent Cooperation Treaty (PCT), it noted. Endeavour Mining PLC (LSE:EDV, TSX:EDV, OTCQX:EDVMF) , the largest gold producer in West Africa, has published its 2021 sustainability report with key environmental, social and governance (ESG) highlights. The company said its total economic contribution to host countries doubled over the prior year to U$2.0bn. Around 80% of its total procurement was in-country, while 95% of its workforce, and almost half of its senior operational management, are nationals. Hercules Site Services PLC (AIM:HERC) chairman Henry Pitman will tell shareholders at the company’s annual shareholder meeting today that the board is confident that the outlook is “bright”, with “unprecedented demand for our services”. The labour and equipment supply company expects to see “a step up in our growth, driven by highly favourable market conditions”, according to a statement ahead of the AGM sharing the contents of Pitman’s speech. ImmuPharma PLC (AIM:IMM, OTC:IMMPF) hailed its recent progress as it said major roadblocks to clinical progress had been effectively cleared. In an update alongside full-year results, it confirmed US partner, Avion Pharmaceuticals, is committed to taking lead asset Lupuzor into phase III clinical trials after the successful completion of a pharmacokinetic study mandated by the US regulator. Franchise Brands PLC (AIM:FRAN) has decided to terminate early the earn-out agreement for Willow Pumps and integrate its staff with the workforce at recent acquisition Filta. Willow Pumps was acquired by Franchise Brands from its managing director Ian Lawrence and his wife in 2019 for an initial £5mln plus a deferred 7.5mln spread over five years. East Star Resources Plc (LSE:EST) said it started a helicopter electromagnetic (HEM) survey on its Rudny Altai volcanogenic massive sulphide (VMS) licences in Eastern Kazakhstan. The survey is anticipated to take 40-50 days, with data processing and technical review and targeting to follow, and is expected to enable the London-listed company to prioritise drilling targets. Sunstone Metals Ltd (ASX:STM) has delivered broad gold and copper assays from four more holes in the upper 500 metres at El Palmar Project in Ecuador, confirming the project as a "substantial" porphyry discovery. The latest assays extend the known, continuous mineralisation to an area of at least 500 x 300 metres with 500 metres of vertical extent from surface, and include:

Genflow Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Genflow Rank

Genflow Frequently Asked Questions (FAQ)

  • When was Genflow founded?

    Genflow was founded in 2016.

  • Where is Genflow's headquarters?

    Genflow's headquarters is located at London.

  • What is Genflow's latest funding round?

    Genflow's latest funding round is Growth Equity.

  • How much did Genflow raise?

    Genflow raised a total of $11M.

  • Who are the investors of Genflow?

    Investors of Genflow include BGF.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.